Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006186906> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W2006186906 endingPage "640" @default.
- W2006186906 startingPage "633" @default.
- W2006186906 abstract "Purpose To explore the potential of multimodality imaging (dynamic contrast–enhanced magnetic resonance imaging [DCE-MRI], apparent diffusion-coefficient diffusion-weighted imaging [ADC-DWI], fluorodeoxyglucose positron emission tomography [FDG-PET], and computed tomography) to define the gross tumor volume (GTV) and organs at risk in radiation therapy planning for pancreatic cancer. Delineated volumetric changes of DCE-MRI, ADC-DWI, and FDG-PET were assessed in comparison with the finding on 3-dimensional/4-dimensional CT with and without intravenous contrast, and with pathology specimens for resectable and borderline resectable cases of pancreatic cancer. Methods and Materials We studied a total of 19 representative patients, whose DCE-MRI, ADC-DWI, and FDG-PET data were reviewed. Gross tumor volume and tumor burden/active region inside pancreatic head/neck or body were delineated on MRI (denoted GTVDCE, and GTVADC), a standardized uptake value (SUV) of 2.5, 40%SUVmax, and 50%SUVmax on FDG-PET (GTV2.5, GTV40%, and GTV50%). Volumes of the pancreas, duodenum, stomach, liver, and kidneys were contoured according to CT (VCT), T1-weighted MRI (VT1), and T2-weighted MRI (VT2) for 7 patients. Results Significant statistical differences were found between the GTVs from DCE-MRI, ADC-DW, and FDG-PET, with a mean and range of 4.73 (1.00-9.79), 14.52 (3.21-25.49), 22.04 (1.00-45.69), 19.10 (4.84-45.59), and 9.80 (0.32-35.21) cm3 for GTVDCE, GTVADC, GTV2.5, GTV40%, and GTV50%, respectively. The mean difference and range in the measurements of maximum dimension of tumor on DCE-MRI, ADC-DW, SUV2.5, 40%SUVmax, and 50%SUVmax compared with pathologic specimens were −0.84 (−2.24 to 0.9), 0.41 (−0.15 to 2.3), 0.58 (−1.41 to 3.69), 0.66 (−0.67 to 1.32), and 0.15 (−1.53 to 2.38) cm, respectively. The T1- and T2-based volumes for pancreas, duodenum, stomach, and liver were generally smaller compared with those from CT, except for the kidneys. Conclusions Differences exists between DCE-, ADC-, and FDG-PET–defined target volumes for RT of pancreatic cancer. Organ at risk volumes based on MRI are generally smaller than those based on CT. Further studies combined with pathologic specimens are required to identify the optimal imaging modality or sequence to define GTV. To explore the potential of multimodality imaging (dynamic contrast–enhanced magnetic resonance imaging [DCE-MRI], apparent diffusion-coefficient diffusion-weighted imaging [ADC-DWI], fluorodeoxyglucose positron emission tomography [FDG-PET], and computed tomography) to define the gross tumor volume (GTV) and organs at risk in radiation therapy planning for pancreatic cancer. Delineated volumetric changes of DCE-MRI, ADC-DWI, and FDG-PET were assessed in comparison with the finding on 3-dimensional/4-dimensional CT with and without intravenous contrast, and with pathology specimens for resectable and borderline resectable cases of pancreatic cancer. We studied a total of 19 representative patients, whose DCE-MRI, ADC-DWI, and FDG-PET data were reviewed. Gross tumor volume and tumor burden/active region inside pancreatic head/neck or body were delineated on MRI (denoted GTVDCE, and GTVADC), a standardized uptake value (SUV) of 2.5, 40%SUVmax, and 50%SUVmax on FDG-PET (GTV2.5, GTV40%, and GTV50%). Volumes of the pancreas, duodenum, stomach, liver, and kidneys were contoured according to CT (VCT), T1-weighted MRI (VT1), and T2-weighted MRI (VT2) for 7 patients. Significant statistical differences were found between the GTVs from DCE-MRI, ADC-DW, and FDG-PET, with a mean and range of 4.73 (1.00-9.79), 14.52 (3.21-25.49), 22.04 (1.00-45.69), 19.10 (4.84-45.59), and 9.80 (0.32-35.21) cm3 for GTVDCE, GTVADC, GTV2.5, GTV40%, and GTV50%, respectively. The mean difference and range in the measurements of maximum dimension of tumor on DCE-MRI, ADC-DW, SUV2.5, 40%SUVmax, and 50%SUVmax compared with pathologic specimens were −0.84 (−2.24 to 0.9), 0.41 (−0.15 to 2.3), 0.58 (−1.41 to 3.69), 0.66 (−0.67 to 1.32), and 0.15 (−1.53 to 2.38) cm, respectively. The T1- and T2-based volumes for pancreas, duodenum, stomach, and liver were generally smaller compared with those from CT, except for the kidneys. Differences exists between DCE-, ADC-, and FDG-PET–defined target volumes for RT of pancreatic cancer. Organ at risk volumes based on MRI are generally smaller than those based on CT. Further studies combined with pathologic specimens are required to identify the optimal imaging modality or sequence to define GTV." @default.
- W2006186906 created "2016-06-24" @default.
- W2006186906 creator A5010816117 @default.
- W2006186906 creator A5041461325 @default.
- W2006186906 creator A5064901596 @default.
- W2006186906 creator A5067310306 @default.
- W2006186906 creator A5078854162 @default.
- W2006186906 date "2014-07-01" @default.
- W2006186906 modified "2023-10-05" @default.
- W2006186906 title "Variability of Target and Normal Structure Delineation Using Multimodality Imaging for Radiation Therapy of Pancreatic Cancer" @default.
- W2006186906 cites W1676308325 @default.
- W2006186906 cites W1965884754 @default.
- W2006186906 cites W1971721996 @default.
- W2006186906 cites W1973186057 @default.
- W2006186906 cites W2024149234 @default.
- W2006186906 cites W2028486697 @default.
- W2006186906 cites W2030577010 @default.
- W2006186906 cites W2036878606 @default.
- W2006186906 cites W2037698226 @default.
- W2006186906 cites W2063122137 @default.
- W2006186906 cites W2065164399 @default.
- W2006186906 cites W2073017415 @default.
- W2006186906 cites W2090391229 @default.
- W2006186906 cites W2104930742 @default.
- W2006186906 cites W2107061083 @default.
- W2006186906 cites W2119914737 @default.
- W2006186906 cites W2158734599 @default.
- W2006186906 cites W2170635365 @default.
- W2006186906 doi "https://doi.org/10.1016/j.ijrobp.2014.02.035" @default.
- W2006186906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24755533" @default.
- W2006186906 hasPublicationYear "2014" @default.
- W2006186906 type Work @default.
- W2006186906 sameAs 2006186906 @default.
- W2006186906 citedByCount "35" @default.
- W2006186906 countsByYear W20061869062015 @default.
- W2006186906 countsByYear W20061869062016 @default.
- W2006186906 countsByYear W20061869062017 @default.
- W2006186906 countsByYear W20061869062018 @default.
- W2006186906 countsByYear W20061869062019 @default.
- W2006186906 countsByYear W20061869062020 @default.
- W2006186906 countsByYear W20061869062021 @default.
- W2006186906 countsByYear W20061869062022 @default.
- W2006186906 countsByYear W20061869062023 @default.
- W2006186906 crossrefType "journal-article" @default.
- W2006186906 hasAuthorship W2006186906A5010816117 @default.
- W2006186906 hasAuthorship W2006186906A5041461325 @default.
- W2006186906 hasAuthorship W2006186906A5064901596 @default.
- W2006186906 hasAuthorship W2006186906A5067310306 @default.
- W2006186906 hasAuthorship W2006186906A5078854162 @default.
- W2006186906 hasConcept C121608353 @default.
- W2006186906 hasConcept C126322002 @default.
- W2006186906 hasConcept C126838900 @default.
- W2006186906 hasConcept C143409427 @default.
- W2006186906 hasConcept C149550507 @default.
- W2006186906 hasConcept C199374082 @default.
- W2006186906 hasConcept C2775842073 @default.
- W2006186906 hasConcept C2777415128 @default.
- W2006186906 hasConcept C2778764654 @default.
- W2006186906 hasConcept C2780210213 @default.
- W2006186906 hasConcept C2989005 @default.
- W2006186906 hasConcept C509974204 @default.
- W2006186906 hasConcept C70816921 @default.
- W2006186906 hasConcept C71924100 @default.
- W2006186906 hasConceptScore W2006186906C121608353 @default.
- W2006186906 hasConceptScore W2006186906C126322002 @default.
- W2006186906 hasConceptScore W2006186906C126838900 @default.
- W2006186906 hasConceptScore W2006186906C143409427 @default.
- W2006186906 hasConceptScore W2006186906C149550507 @default.
- W2006186906 hasConceptScore W2006186906C199374082 @default.
- W2006186906 hasConceptScore W2006186906C2775842073 @default.
- W2006186906 hasConceptScore W2006186906C2777415128 @default.
- W2006186906 hasConceptScore W2006186906C2778764654 @default.
- W2006186906 hasConceptScore W2006186906C2780210213 @default.
- W2006186906 hasConceptScore W2006186906C2989005 @default.
- W2006186906 hasConceptScore W2006186906C509974204 @default.
- W2006186906 hasConceptScore W2006186906C70816921 @default.
- W2006186906 hasConceptScore W2006186906C71924100 @default.
- W2006186906 hasIssue "3" @default.
- W2006186906 hasLocation W20061869061 @default.
- W2006186906 hasLocation W20061869062 @default.
- W2006186906 hasOpenAccess W2006186906 @default.
- W2006186906 hasPrimaryLocation W20061869061 @default.
- W2006186906 hasRelatedWork W1965188844 @default.
- W2006186906 hasRelatedWork W1982187894 @default.
- W2006186906 hasRelatedWork W2005999920 @default.
- W2006186906 hasRelatedWork W2083210814 @default.
- W2006186906 hasRelatedWork W2111347914 @default.
- W2006186906 hasRelatedWork W2117290479 @default.
- W2006186906 hasRelatedWork W2182920042 @default.
- W2006186906 hasRelatedWork W2352040555 @default.
- W2006186906 hasRelatedWork W2589832859 @default.
- W2006186906 hasRelatedWork W2911545827 @default.
- W2006186906 hasVolume "89" @default.
- W2006186906 isParatext "false" @default.
- W2006186906 isRetracted "false" @default.
- W2006186906 magId "2006186906" @default.
- W2006186906 workType "article" @default.